000 | 01962 a2200553 4500 | ||
---|---|---|---|
005 | 20250513203743.0 | ||
264 | 0 | _c20000316 | |
008 | 200003s 0 0 eng d | ||
022 | _a0263-6352 | ||
024 | 7 |
_a10.1097/00004872-199917121-00023 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFabris, B | |
245 | 0 | 0 |
_aControl of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats. _h[electronic resource] |
260 |
_bJournal of hypertension _cDec 1999 |
||
300 |
_a1925-31 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aDiabetic Angiopathies _xdrug therapy |
650 | 0 | 4 |
_aDiabetic Nephropathies _xphysiopathology |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDiuretics |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aEnalapril _xanalogs & derivatives |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 |
_aHydralazine _xpharmacology |
650 | 0 | 4 |
_aHydrochlorothiazide _xpharmacology |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aHypertrophy |
650 | 0 | 4 |
_aKidney _xpathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProteinuria _xurine |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred SHR |
650 | 0 | 4 |
_aReserpine _xpharmacology |
650 | 0 | 4 |
_aSodium Chloride Symporter Inhibitors _xpharmacology |
700 | 1 | _aCandido, R | |
700 | 1 | _aArmini, L | |
700 | 1 | _aFischetti, F | |
700 | 1 | _aCalci, M | |
700 | 1 | _aBardelli, M | |
700 | 1 | _aFazio, M | |
700 | 1 | _aCampanacci, L | |
700 | 1 | _aCarretta, R | |
773 | 0 |
_tJournal of hypertension _gvol. 17 _gno. 12 Pt 2 _gp. 1925-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004872-199917121-00023 _zAvailable from publisher's website |
999 |
_c10657954 _d10657954 |